Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


07.08.2017

1 Acta Obstet Gynecol Scand
4 Am J Obstet Gynecol
4 Aust N Z J Obstet Gynaecol
3 BMC Cancer
2 BMJ
1 Br J Cancer
1 Cancer
1 Clin Cancer Res
1 Eur J Cancer
7 Eur J Obstet Gynecol Reprod Biol
3 Gynecol Endocrinol
6 Gynecol Oncol
4 Int J Gynaecol Obstet
1 J Clin Oncol
3 Lancet
1 Lancet Infect Dis
1 Lancet Oncol
3 Obstet Gynecol
12 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. SABETI RAD Z, Friberg B, Henic E, Rylander L, et al
    Prematurity and neonatal outcome including congenital malformations after maternal malignancy within six months prior or during pregnancy.
    Acta Obstet Gynecol Scand. 2017 Aug 4. doi: 10.1111/aogs.13197.
    PubMed     Text format     Abstract available


    Am J Obstet Gynecol

  2. DILLEY S, Scarinci I, Kimberlin D, Straughn JM Jr, et al
    Preventing HPV-Related Cancers - We Are All In This Together.
    Am J Obstet Gynecol. 2017 Feb 21. pii: S0002-9378(17)30299.
    PubMed     Text format     Abstract available

  3. SPENCER JC, Louie M, Moulder JK, Ellis V, et al
    Cost effectiveness of treatments for heavy menstrual bleeding.
    Am J Obstet Gynecol. 2017 Jul 25. pii: S0002-9378(17)30868.
    PubMed     Text format     Abstract available

  4. BARNARD EP, AbdElmagied AM, Vaughan LE, Weaver AL, et al
    Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis.
    Am J Obstet Gynecol. 2017;216:500.
    PubMed     Text format     Abstract available

  5. MORIN A, Leonard G, Gougeon V, Cyr MP, et al
    Efficacy of transcranial direct-current stimulation in women with provoked vestibulodynia.
    Am J Obstet Gynecol. 2017;216:584.
    PubMed     Text format     Abstract available


    Aust N Z J Obstet Gynaecol

  6. BOND D, Raynes-Greenow C, Gordon A
    Bereaved parents' experience of care and follow-up after stillbirth in Sydney hospitals.
    Aust N Z J Obstet Gynaecol. 2017 Aug 4. doi: 10.1111/ajo.12684.
    PubMed     Text format     Abstract available

  7. STEPHENS B, Sethna F, Crispin P
    Postpartum obstetric red cell transfusion practice: A retrospective study in a tertiary obstetric centre.
    Aust N Z J Obstet Gynaecol. 2017 Aug 4. doi: 10.1111/ajo.12680.
    PubMed     Text format     Abstract available

  8. BROWN J, Kapurubandara S, Gibbs E, King J, et al
    The Great Divide: Country of birth as a risk factor for obstetric anal sphincter injuries.
    Aust N Z J Obstet Gynaecol. 2017 Aug 4. doi: 10.1111/ajo.12672.
    PubMed     Text format     Abstract available

  9. MORRIS JM, Totterdell J, Bin YS, Ford JB, et al
    Contribution of maternal age, medical and obstetric history to maternal and perinatal morbidity/mortality for women aged 35 or older.
    Aust N Z J Obstet Gynaecol. 2017 Aug 4. doi: 10.1111/ajo.12674.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. WANG W, Hou X, Yan J, Shen J, et al
    Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    BMC Cancer. 2017;17:510.
    PubMed     Text format     Abstract available

  11. LI J, Ning NY, Rao QX, Chen R, et al
    Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.
    BMC Cancer. 2017;17:517.
    PubMed     Text format     Abstract available

  12. BREBI P, Ili CG, Andana A, Menzel D, et al
    Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile.
    BMC Cancer. 2017;17:518.
    PubMed     Text format     Abstract available


    BMJ

  13. HUYBRECHTS KF, Bateman BT, Desai RJ, Hernandez-Diaz S, et al
    Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
    BMJ. 2017;358:j3326.
    PubMed     Text format     Abstract available

  14. PATRICK SW, Cooper WO, Davis MM
    Prescribing opioids and psychotropic drugs in pregnancy.
    BMJ. 2017;358:j3616.
    PubMed     Text format    


    Br J Cancer

  15. TABUNG FK, Huang T, Giovannucci EL, Smith-Warner SA, et al
    The inflammatory potential of diet and ovarian cancer risk: results from two prospective cohort studies.
    Br J Cancer. 2017 Aug 3. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  16. EVERETT EN
    The evolving role of cytopathology in the era of neoadjuvant chemotherapy for the accurate pathologic diagnosis of epithelial ovarian cancer.
    Cancer. 2017 Jul 31. doi: 10.1002/cncy.21894.
    PubMed     Text format    


    Clin Cancer Res

  17. WEIGELT B, Comino-Mendez I, de Bruijn I, Tian L, et al
    Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.
    Clin Cancer Res. 2017 Aug 1. pii: clincanres.0544.2017.
    PubMed     Text format     Abstract available


    Eur J Cancer

  18. VERGOTE IB, Smith DC, Berger R, Kurzrock R, et al
    A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma.
    Eur J Cancer. 2017;83:229-236.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  19. SOFIYEVA N, Oral E
    Letter from original author re. Does telomerase activity have an effect on infertility in patients with endometriosis? Methodological issues.
    Eur J Obstet Gynecol Reprod Biol. 2017 Jul 12. pii: S0301-2115(17)30334.
    PubMed     Text format    

  20. VAN DE VEN J, van Baaren GJ, Fransen AF, van Runnard Heimel PJ, et al
    Cost-effectiveness of simulation-based team training in obstetric emergencies (TOSTI study).
    Eur J Obstet Gynecol Reprod Biol. 2017;216:130-137.
    PubMed     Text format     Abstract available

  21. BEL S, Billard C, Godet J, Viviani V, et al
    Risk of malignancy on suspicion of polyps in menopausal women.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:138-142.
    PubMed     Text format     Abstract available

  22. VAN DER AA JE, Tancredi A, Goverde AJ, Velebil P, et al
    What European gynaecologists need to master: Consensus on medical expertise outcomes of pan-European postgraduate training in obstetrics & gynaecology.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:143-152.
    PubMed     Text format     Abstract available

  23. AL-FAR HFM, Tjessem IH, Fuglsang J, Lauszus FF, et al
    Preeclampsia is associated with increased ambulatory arterial stiffness index in type 1 diabetes mellitus.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:153-158.
    PubMed     Text format     Abstract available

  24. DE HAAN J, Van Calsteren K, Lok CAR, de Groot CJM, et al
    Comment on "Maternal and perinatal outcomes in pregnancy-associated melanoma. Report of two cases and a systematic literature review".
    Eur J Obstet Gynecol Reprod Biol. 2017 Jul 23. pii: S0301-2115(17)30359.
    PubMed     Text format    

  25. FANG D, Moreno M, Garfield RE, Kuon R, et al
    Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:164-168.
    PubMed     Text format     Abstract available


    Gynecol Endocrinol

  26. JIANG JF, Xiao SS, Xue M
    Decreased expression of interleukin-37 in the ectopic and eutopic endometria of patients with adenomyosis.
    Gynecol Endocrinol. 2017 Aug 1:1-4. doi: 10.1080/09513590.2017.1354367.
    PubMed     Text format     Abstract available

  27. VILLARROEL C, Salinas A, Lopez P, Kohen P, et al
    Anti-Mullerian hormone in type 2 and gestational diabetes during the second half of pregnancy: relationship with sexual steroid levels and metabolic parameters.
    Gynecol Endocrinol. 2017 Jul 31:1-5. doi: 10.1080/09513590.2017.1359824.
    PubMed     Text format     Abstract available

  28. YBARRA M, Franco RR, Cominato L, Sampaio RB, et al
    Polycystic Ovary Syndrome among Obese Adolescents.
    Gynecol Endocrinol. 2017 Jul 29:1-4. doi: 10.1080/09513590.2017.1359250.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  29. COHN DE, Sill MW, Walker JL, O'Malley D, et al
    Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin(R)) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Jul 27. pii: S0090-8258(17)31175.
    PubMed     Text format     Abstract available

  30. MEIRELES CG, Pereira SA, Valadares LP, Rego DF, et al
    Effects of metformin on endometrial cancer: Systematic review and meta-analysis.
    Gynecol Oncol. 2017 Jul 28. pii: S0090-8258(17)31136.
    PubMed     Text format     Abstract available

  31. HOGEN L, Brar H, Covens A, Bassiouny D, et al
    Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?
    Gynecol Oncol. 2017 Jul 28. pii: S0090-8258(17)31168.
    PubMed     Text format     Abstract available

  32. FADER AN, Bergstrom J, Jernigan A, Tanner EJ 3rd, et al
    Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
    Gynecol Oncol. 2017 Jul 30. pii: S0090-8258(17)31167.
    PubMed     Text format     Abstract available

  33. FLEMING ND, Coleman RL, Tung C, Westin SN, et al
    Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer.
    Gynecol Oncol. 2017 Jul 31. pii: S0090-8258(17)31177.
    PubMed     Text format     Abstract available

  34. CHOI C, Kim WY, Lee DH, Oh SS, et al
    Cytoreduction of bulky para-aortic lymphadenopathy from metastatic ovarian cancer.
    Gynecol Oncol. 2017 Jul 31. pii: S0090-8258(17)31173.
    PubMed     Text format    


    Int J Gynaecol Obstet

  35. MABUCHI S, Kozasa K, Kimura T
    Radical hysterectomy after radiotherapy for recurrent or persistent cervical cancer.
    Int J Gynaecol Obstet. 2017 Jul 28. doi: 10.1002/ijgo.12284.
    PubMed     Text format     Abstract available

  36. MOULDER JK, Siedhoff MT, Melvin KL, Jarvis EG, et al
    Risk of appendiceal endometriosis among women with deep-infiltrating endometriosis.
    Int J Gynaecol Obstet. 2017 Jul 29. doi: 10.1002/ijgo.12286.
    PubMed     Text format     Abstract available

  37. SANTANA DS, Cecatti JG, Haddad SM, Parpinelli MA, et al
    Severe maternal morbidity and perinatal outcomes of multiple pregnancy in the Brazilian Network for the Surveillance of Severe Maternal Morbidity.
    Int J Gynaecol Obstet. 2017 Jul 29. doi: 10.1002/ijgo.12287.
    PubMed     Text format     Abstract available

  38. MAHER MA, Abdelaziz A, Shehata YA
    Effect of follicular diameter at the time of ovulation triggering on pregnancy outcomes during intrauterine insemination.
    Int J Gynaecol Obstet. 2017 Aug 3. doi: 10.1002/ijgo.12291.
    PubMed     Text format     Abstract available


    J Clin Oncol

  39. RUTTEN MJ, van Meurs HS, van de Vrie R, Gaarenstroom KN, et al
    Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.
    J Clin Oncol. 2016 Dec 28:JCO2016692962.
    PubMed     Text format     Abstract available


    Lancet

  40. BANERJEE S
    Bevacizumab in cervical cancer: a step forward for survival.
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31965.
    PubMed     Text format    

  41. TEWARI KS, Sill MW, Penson RT, Huang H, et al
    Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31607.
    PubMed     Text format     Abstract available

  42. LANGDAHL BL, Libanati C, Crittenden DB, Bolognese MA, et al
    Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial.
    Lancet. 2017 Jul 26. pii: S0140-6736(17)31613.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  43. UNEMO M, Bradshaw CS, Hocking JS, de Vries HJC, et al
    Sexually transmitted infections: challenges ahead.
    Lancet Infect Dis. 2017 Jul 7. pii: S1473-3099(17)30310.
    PubMed     Text format     Abstract available


    Lancet Oncol

  44. PUJADE-LAURAINE E, Ledermann JA, Selle F, Gebski V, et al
    Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Lancet Oncol. 2017 Jul 25. pii: S1470-2045(17)30469.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  45. GAYDOS CA, Beqaj S, Schwebke JR, Lebed J, et al
    Clinical Validation of a Test for the Diagnosis of Vaginitis.
    Obstet Gynecol. 2017;130:181-189.
    PubMed     Text format     Abstract available


  46. Committee Opinion No 706 Summary: Sexual Health.
    Obstet Gynecol. 2017;130:251-252.
    PubMed     Text format     Abstract available


  47. Committee Opinion No. 708 Summary: Improving Awareness of and Screening for Health Risks Among Sex Workers.
    Obstet Gynecol. 2017;130:253-254.
    PubMed     Text format     Abstract available


    PLoS One

  48. MARTINEZ-NAVA GA, Fernandez-Nino JA, Madrid-Marina V, Torres-Poveda K, et al
    Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence.
    PLoS One. 2016;11:e0157344.
    PubMed     Text format     Abstract available

  49. WANG L, Wang P, Ren Y, Du J, et al
    Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China.
    PLoS One. 2016;11:e0160698.
    PubMed     Text format     Abstract available

  50. PARK B, Kim SI, Seo SS, Kang S, et al
    Health Behaviors and Associated Sociodemographic Factors in Cervical Cancer Survivors Compared with Matched Non-Cancer Controls.
    PLoS One. 2016;11:e0160682.
    PubMed     Text format     Abstract available

  51. CASTILLO M, Astudillo A, Clavero O, Velasco J, et al
    Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.
    PLoS One. 2016;11:e0161403.
    PubMed     Text format     Abstract available

  52. PARK H, Konda KA, Roberts CP, Maguina JL, et al
    Risk Factors Associated with Incident Syphilis in a Cohort of High-Risk Men in Peru.
    PLoS One. 2016;11:e0162156.
    PubMed     Text format     Abstract available

  53. VICETTI MIGUEL RD, Quispe Calla NE, Pavelko SD, Cherpes TL, et al
    Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.
    PLoS One. 2016;11:e0162445.
    PubMed     Text format     Abstract available

  54. TUMBARELLO DA, Andrews MR, Brenton JD
    SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells.
    PLoS One. 2016;11:e0162698.
    PubMed     Text format     Abstract available

  55. HUANG Y, Li Y, Wang FF, Lv W, et al
    Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8.
    PLoS One. 2016;11:e0162378.
    PubMed     Text format     Abstract available

  56. VAN LENT S, De Vos WH, Huot Creasy H, Marques PX, et al
    Analysis of Polymorphic Membrane Protein Expression in Cultured Cells Identifies PmpA and PmpH of Chlamydia psittaci as Candidate Factors in Pathogenesis and Immunity to Infection.
    PLoS One. 2016;11:e0162392.
    PubMed     Text format     Abstract available

  57. XIAO X, Cai F, Niu X, Shi H, et al
    Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies.
    PLoS One. 2016;11:e0163257.
    PubMed     Text format     Abstract available

  58. BEEK TF, Cohen-Kettenis PT, Bouman WP, de Vries AL, et al
    Gender Incongruence of Childhood: Clinical Utility and Stakeholder Agreement with the World Health Organization's Proposed ICD-11 Criteria.
    PLoS One. 2017;12:e0168522.
    PubMed     Text format     Abstract available

  59. REMIS RS, Liu J, Loutfy MR, Tharao W, et al
    Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.
    PLoS One. 2016;11:e0158090.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: